Concepedia

Susan Zeigenfuss

SZ

Statistics

Publications

4

Citations

1.4K

H-Index

4

Active since

2017

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Yonsei University

The Netherlands Cancer Institute

The University of Texas MD Anderson Cancer Center

Institut Claudius Regaud

Susan Zeigenfuss is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in immune checkpoint inhibitors, oncology, and pembrolizumab therapy.

Publications per year

2017–2019

4

Publications

4